CLINICAL_TRIALS
trial_result
· 2016-02-25
Clinical Trial Update: Lurasidone Pediatric Autism Study [Phase 3]
Summary
A Phase 3 pediatric trial of lurasidone for autism spectrum disorder has completed, with results posted in February 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Autism | Phase 3 | Status: COMPLETED | Results posted: 2016-02-25